Tabula Rasa HealthCare, Inc. (TRHC) Stock Analysis

Tabula Rasa HealthCare, Inc. (TRHC) Healthcare & Pipeline Overview

Tabula Rasa HealthCare, Inc. (TRHC) delivers medication risk management solutions through its cloud-based software and services. The company's platforms, like EireneRx and MedWise, support healthcare providers in optimizing medication regimens and improving patient outcomes, serving healthcare organizations, pharmacies, and health plans across the United States.

What Is the Investment Thesis for TRHC?

Tabula Rasa HealthCare presents an investment opportunity within the growing healthcare technology sector, specifically in medication risk management. The company's cloud-based platforms, such as EireneRx and MedWise, address the critical need for medication optimization and safety, potentially reducing adverse drug events and improving patient outcomes. The increasing adoption of value-based care models and the focus on reducing healthcare costs could drive demand for Tabula Rasa's solutions. However, the company's negative profit margin of -25.8% indicates profitability challenges. Successful execution of growth strategies and a shift towards profitability are crucial for long-term value creation. Investors should closely monitor the company's ability to expand its customer base, improve operational efficiency, and achieve sustainable profitability.

Based on FMP financials and quantitative analysis

TRHC Key Highlights

Market capitalization of $284M reflects investor valuation of the company's future growth potential.

• Negative profit margin of -25.8% indicates ongoing challenges in achieving profitability.
• Gross margin of 22.3% suggests potential for improvement through operational efficiencies and pricing strategies.
• The company serves approximately 150 healthcare organizations, indicating a significant market presence.
• Partnerships with 350 health plans and approximately 18,000 retail pharmacies demonstrate a broad distribution network.

Who Are TRHC's Competitors?

TRHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TRHC's Key Strengths?

Comprehensive suite of medication risk management solutions.

• Cloud-based technology platform.
• Established relationships with healthcare organizations and pharmacies.
• Expertise in medication safety and optimization.

What Are TRHC's Weaknesses?

Negative profit margin.

• High operating expenses.
• Reliance on a limited number of key customers.
• Competition from larger healthcare technology companies.

What Could Drive TRHC Stock Higher?

Potential acquisitions or partnerships to expand product offerings and market reach.

• Increasing adoption of value-based care models driving demand for medication risk management solutions.
• Expansion of the company's presence within the PACE market.
• Development and launch of new AI-powered tools for medication optimization.

What Are the Key Risks for TRHC?

Financial-distress signal — its Altman Z-Score of -0.69 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Insider selling — insiders were net sellers of roughly $304.3B recently.
• Regulatory changes affecting medication management practices.
• Increased competition from larger healthcare technology companies.
• Cybersecurity risks and data breaches.
• Economic downturn affecting healthcare spending.
• Challenges in achieving and maintaining profitability.

What Are the Growth Opportunities for TRHC?

• Expansion within the PACE market: Tabula Rasa's CareVention HealthCare segment offers solutions tailored for Programs of All-Inclusive Care for the Elderly (PACE). With the aging population and increasing demand for comprehensive care programs, expanding its presence within the PACE market represents a significant growth opportunity. The PACE market is projected to continue growing, driven by the need to provide integrated care for older adults with complex health needs. Timeline: Ongoing.
• Increased adoption of medication therapy management (MTM) services: Tabula Rasa's MedWise HealthCare segment provides medication therapy management (MTM) software and services. As healthcare providers and payers increasingly recognize the value of MTM in improving patient outcomes and reducing healthcare costs, the demand for MTM solutions is expected to grow. This trend presents an opportunity for Tabula Rasa to expand its MTM business and attract new customers. Timeline: Ongoing.
• Strategic partnerships and acquisitions: Tabula Rasa can pursue strategic partnerships and acquisitions to expand its product offerings, enter new markets, and enhance its competitive position. Collaborating with other healthcare technology companies or acquiring complementary businesses can accelerate growth and create synergies. Identifying and integrating synergistic acquisitions will be key to capitalizing on this opportunity. Timeline: Ongoing.
• Leveraging data analytics and artificial intelligence: Tabula Rasa can leverage data analytics and artificial intelligence (AI) to enhance its medication risk management solutions and provide more personalized and proactive care. By analyzing patient data and identifying patterns, the company can develop AI-powered tools that predict and prevent adverse drug events, optimize medication regimens, and improve patient outcomes. Timeline: Ongoing.
• Expanding into new geographic markets: While Tabula Rasa primarily operates in the United States, expanding into new geographic markets represents a long-term growth opportunity. The need for medication risk management solutions exists globally, and Tabula Rasa can leverage its expertise and technology to serve healthcare organizations and patients in other countries. Conducting market research and adapting its solutions to meet local needs will be crucial for successful international expansion. Timeline: Future.

What Are TRHC's Competitive Advantages?

• Proprietary technology: Cloud-based platforms and algorithms for medication risk management.
• Data assets: Accumulation of patient medication data and clinical insights.
• Established relationships: Partnerships with healthcare organizations, pharmacies, and health plans.
• Expertise: Deep understanding of medication safety and optimization.

What Does TRHC Do?

Founded in 2009 and headquartered in Moorestown, New Jersey, Tabula Rasa HealthCare, Inc. operates as a healthcare technology company dedicated to improving medication safety and efficacy. The company provides a suite of cloud-based software solutions and services designed to help healthcare organizations, pharmacies, and health plans optimize medication regimens, reduce adverse drug events, and improve patient outcomes. Tabula Rasa operates through two segments: CareVention HealthCare and MedWise HealthCare. CareVention HealthCare focuses on providing solutions for Programs of All-Inclusive Care for the Elderly (PACE), offering tools like TruChart, an electronic health record (EHR) system, and PACElogic, a platform for care coordination and financial management. MedWise HealthCare offers platforms like EireneRx, a medication decision-support and e-prescribing platform, and MedWise medication therapy management software. These platforms aid in identifying and resolving medication-related problems. Additionally, Tabula Rasa offers DoseMeRx, a decision support software for dose optimization, and PrescribeWellness, a patient engagement center platform. The company also provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services. As of December 31, 2021, Tabula Rasa served approximately 150 healthcare organizations, 350 health plans, and approximately 18,000 retail pharmacies.

What Products and Services Does TRHC Offer?

• Provides cloud-based medication decision-support and e-prescribing platforms.
• Offers medication therapy management software to identify and resolve medication-related problems.
• Delivers electronic health records (EHR), care coordination, and financial management solutions for PACE programs.
• Provides dose optimization software leveraging pharmacokinetic drug models and patient characteristics.
• Offers a patient engagement center platform.
• Provides clinical pharmacist collaboration and prescription fulfillment services.
• Offers pharmacy benefit management services.
• Provides health plan management services, including risk adjustment.

How Does TRHC Make Money?

• Software-as-a-Service (SaaS) model: Generates revenue through subscriptions to its cloud-based software platforms.
• Service fees: Charges fees for clinical pharmacist collaboration, prescription fulfillment, and pharmacy benefit management services.
• Health plan management services: Earns revenue from providing risk adjustment and third-party administrator services to health plans.

What Industry Does TRHC Operate In?

Tabula Rasa HealthCare operates in the healthcare information technology sector, which is experiencing significant growth driven by the increasing adoption of digital health solutions and the need for improved healthcare efficiency. The market is competitive, with companies offering various solutions for medication management, electronic health records, and care coordination. Tabula Rasa differentiates itself through its focus on medication risk management and its suite of integrated cloud-based platforms. The company's solutions cater to healthcare organizations, pharmacies, and health plans, positioning it within a broad segment of the healthcare ecosystem.

Who Are TRHC's Key Customers?

• Healthcare organizations: Hospitals, clinics, and integrated delivery networks.
• Pharmacies: Retail pharmacies and specialty pharmacies.
• Health plans: Managed care organizations and government-sponsored health plans.
• Programs of All-Inclusive Care for the Elderly (PACE): Organizations providing comprehensive care to older adults.

The most recent 12 insider filings for Tabula Rasa HealthCare, Inc. break down as 12 sales and 0 purchases. On net that is roughly 90.2M shares disposed (about $304.3B), a signal worth weighing alongside the fundamentals.

TRHC Valuation & Market Position

With a $284M market cap, Tabula Rasa HealthCare, Inc. sits in the micro-cap segment of the market.

Key Financial Metrics

Return on assets is -20.1%, showing how much profit it generates from its asset base. Its free cash flow yield is -7.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.67 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -30.3%, the inverse of the P/E and a quick read on earnings relative to price.

Tabula Rasa HealthCare, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.69 places it in the distress zone, a signal of elevated financial risk.

Company Profile

Tabula Rasa HealthCare, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Moorestown, US. The company is led by CEO Brian W. Adams. TRHC has traded publicly since 2016.

TRHC Financials

TRHC Latest News

Tabula Rasa HealthCare, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources